Pulse Biosciences (PLSE) Return on Sales (2021 - 2025)

Pulse Biosciences has reported Return on Sales for 4 years, with the latest figure at 2.25% in Q3 2025.

• For the quarter ending Q3 2025, Return on Sales changed N/A year-over-year to 2.25%; the trailing twelve-month figure through Sep 2025 stood at 3.78% (changed N/A YoY), and the FY2022 full-year result was 0.84%, changed N/A from the prior year.
• Return on Sales for Q3 2025 stood at 2.25%, down from 43.86% in the prior quarter.
• The five-year high for Return on Sales was 52.16% in Q2 2023, with the low at 2.25% in Q3 2025.
• Average Return on Sales over 4 years is 10.05%, with a median of 0.32% recorded in 2022.
• Peak annual rise in Return on Sales reached 5263 bps in 2023, while the deepest fall reached 136 bps in 2023.
• Tracing PLSE's Return on Sales over 4 years: stood at 0.18% in 2021, then soared by 5695 bps to 10.22% in 2022, then jumped by 329 bps to 43.86% in 2023, then sank by 105 bps to 2.25% in 2025.
• The last three Return on Sales figures came in at 2.25% (Q3 2025), 43.86% (Q3 2023), and 52.16% (Q2 2023), per Business Quant data.

Peer Comparison